Magnetar Financial LLC
Institutional investor · Portfolio as of Q4 2019
Top Holdings524 positions
ALLERGAN PLC | 1.3M | $243M | 5.1% | — | — | 3 qtrssince 2019-Q2 | Decreased 0 |
WELLCARE HEALTH PLANS INC | 670,556 | $221.4M | 4.6% | — | — | 3 qtrssince 2019-Q2 | Decreased 0 |
| 14.9M | $202.7M | 4.2% | — | — | 3 qtrssince 2019-Q2 | Increased 56 | |
TD AMERITRADE HOLDING CORP | 3.9M | $195.3M | 4.1% | $50.94 | 0.00% | 1 qtr | New 85 |
WABCO HOLDINGS INC | 1.4M | $193.5M | 4.0% | — | — | 3 qtrssince 2019-Q2 | Decreased 0 |
TIFFANY & CO | 1.4M | $188.3M | 3.9% | — | — | 1 qtr | New 84 |
WRIGHT MEDICAL GROUP NV | 6M | $183.5M | 3.8% | — | — | 1 qtr | New 84 |
CYPRESS SEMICONDUCTOR CORP | 7.6M | $178.2M | 3.7% | — | — | 3 qtrssince 2019-Q2 | Increased 56 |
MELLANOX TECHNOLOGIES LTD | 1.5M | $172.2M | 3.6% | — | — | 3 qtrssince 2019-Q2 | Decreased 0 |
MEDICINES COMPANY | 1.9M | $160.8M | 3.4% | — | — | 1 qtr | New 84 |
ACACIA COMMUNICATIONS INC | 1.9M | $128.5M | 2.7% | — | — | 2 qtrssince 2019-Q3 | Decreased 0 |
ADVANCED DISPOSAL SERVICES I | 3.2M | $106.3M | 2.2% | — | — | 3 qtrssince 2019-Q2 | Decreased 0 |
AUDENTES THERAPEUTICS INC | 1.6M | $95.4M | 2.0% | — | — | 1 qtr | New 68 |
RA PHARMACEUTICALS INC | 1.8M | $86.3M | 1.8% | — | — | 1 qtr | New 68 |
UBER TECHNOLOGIES INC | 2.9M | $85.1M | 1.8% | $30.29 | -1.82% | 2 qtrssince 2019-Q3 | Decreased 0 |
| 16.3M | $85M | 1.8% | — | — | 3 qtrssince 2019-Q2 | Decreased 0 | |
FITBIT INC - A | 12.2M | $80.3M | 1.7% | — | — | 1 qtr | New 68 |
KEMET CORP | 2.9M | $77.8M | 1.6% | — | — | 1 qtr | New 68 |
ENERGY TRANSFER L P | 4.8M | $61.7M | 1.3% | $7.43 | -3.79% | 3 qtrssince 2019-Q2 | Increased 56 |
STARS GROUP INC/THE | 2.1M | $53.9M | 1.1% | — | — | 1 qtr | New 67 |
Magnetar Financial LLC manages $4.8B across 524 positions as of Q4 2019. Top holdings: AGN (5.1%), WCG (4.6%), CZRN (4.2%). Fund DNA: Momentum Trader. HoldingsIntel Score: 3/5.0.
Active quarter - 238 new positions, 185 exits, 69 increased. Top move: AMTD (NEW, conviction 85). Portfolio: $4.8B across 524 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR